In trial 2, 75.8% of patients received valsartan/HCTZ alone over the complete study period. The changes in systolic (SBP) and diastolic (DBP) blood pressure are presented in table II and figure 1.
OBJECTIVE: To examine in patients treated with a regimen including single-pill combinations (SPCs) of amlodipine/valsartan (1) blood pressure (BP) reduction and control, total cardiovascular risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback